Literature DB >> 8951823

Pseudomonas exotoxin exhibits increased sensitivity to furin when sequences at the cleavage site are mutated to resemble the arginine-rich loop of diphtheria toxin.

M F Chiron1, M Ogata, D J FitzGerald.   

Abstract

To be toxic for mammalian cells, Pseudomonas exotoxin (PE) requires proteolytic cleavage between Arg-279 and Gly-280. Cleavage, which is mediated by the cellular protease furin, generates an active C-terminal fragment which translocates to the cytosol and inhibits protein synthesis. In vitro, furin-mediated cleavage is optimal at pH 5.5 with a relatively slow turnover rate. Within cells, only 5-10% of cell-associated PE is cleaved. To investigate the reasons for this inefficient cleavage, the amino acid composition near the cleavage site was altered to resemble more closely the arginine-rich sequence from the functionally similar region of diphtheria toxin (DT). Four PE-DT mutants were generated, whereby 1, 5, 6 or 8 amino acids at the PE-cleavage site were changed to amino acids found at the DT-cleavage site. Mutant proteins were expressed in Escherichia coli, purified and then analysed for their susceptibility to cleavage by furin and trypsin, susceptibility to cell-mediated cleavage, and cytotoxic activity relative to wild-type PE. At pH 5.5, the rate of both furin-mediated cleavage and trypsin-mediated cleavage increased dramatically when amino acids in PE were altered to resemble the DT sequence. This increase did not alter the pH optimum for furin-mediated cleavage of PE toxins, which remained at pH 5.0-5.5. When radioactive versions of selected PE-DT proteins were added to intact cells, an increase in the percentage of molecules that were cleaved relative to wild-type PE was also seen. However, changes that favoured increased proteolysis apparently interfered with other important toxin functions because none of the PE-DT proteins exhibited enhanced toxicity for cells when compared with the activity of wild-type PE.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8951823     DOI: 10.1046/j.1365-2958.1996.d01-1721.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  8 in total

1.  Renal excretion of recombinant immunotoxins containing pseudomonas exotoxin.

Authors:  Roberta Traini; Robert J Kreitman
Journal:  Bioconjug Chem       Date:  2011-03-16       Impact factor: 4.774

2.  Inclusion of a furin-sensitive spacer enhances the cytotoxicity of ribotoxin restrictocin containing recombinant single-chain immunotoxins.

Authors:  A Goyal; J K Batra
Journal:  Biochem J       Date:  2000-01-15       Impact factor: 3.857

Review 3.  Immunotoxins for leukemia.

Authors:  Alan S Wayne; David J Fitzgerald; Robert J Kreitman; Ira Pastan
Journal:  Blood       Date:  2014-02-27       Impact factor: 22.113

4.  Contextualizing the Use of Moxetumomab Pasudotox in the Treatment of Relapsed or Refractory Hairy Cell Leukemia.

Authors:  Robert J Kreitman; Ira Pastan
Journal:  Oncologist       Date:  2019-10-18

5.  Processing of Pseudomonas aeruginosa exotoxin A is dispensable for cell intoxication.

Authors:  Juliette Morlon-Guyot; Jocelyn Méré; Anne Bonhoure; Bruno Beaumelle
Journal:  Infect Immun       Date:  2009-04-20       Impact factor: 3.609

6.  Involvement of ATP-dependent Pseudomonas exotoxin translocation from a late recycling compartment in lymphocyte intoxication procedure.

Authors:  M Alami; M P Taupiac; H Reggio; A Bienvenüe; B Beaumelle
Journal:  Mol Biol Cell       Date:  1998-02       Impact factor: 3.612

Review 7.  Strategies to mitigate the on- and off-target toxicities of recombinant immunotoxins: an antibody engineering perspective.

Authors:  Mengyu Li; Sen Mei; Yi Yang; Yuelei Shen; Lei Chen
Journal:  Antib Ther       Date:  2022-06-16

8.  Towards Engineering Novel PE-Based Immunotoxins by Targeting Them to the Nucleus.

Authors:  Marta Borowiec; Michal Gorzkiewicz; Joanna Grzesik; Aurelia Walczak-Drzewiecka; Anna Salkowska; Ewelina Rodakowska; Kamil Steczkiewicz; Leszek Rychlewski; Jaroslaw Dastych; Krzysztof Ginalski
Journal:  Toxins (Basel)       Date:  2016-11-10       Impact factor: 5.075

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.